Celularity CELU
NASDAQ CELU
$0.96 -0.09 (-8.51%)
As of: Oct 23, 2026 · 3:59 PM EDT

Celularity (CELU) EV to EBIT (2020)

Updated

Celularity's (CELU) EV to EBIT came in at 61.84 for Q4 2020.

Analysis

Celularity (CELU) EV to EBIT (2020) Analysis & Trends

For the trailing twelve months through Dec 31, 2020, EV to EBIT at Celularity was 61.56.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Celularity 28.25 Mn 21.00 Mn 3.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 61.84
API Access

Celularity EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CELU&period=max&api_key=YOUR_API_KEY